.webp)
Gwyneth Paltrow and neuroscientist Andrew Huberman explore retatrutide, a new triple-agonist GLP-1 therapy said to reduce side effects and spare muscle.
Gwyneth Paltrow and neuroscientist Andrew Huberman explore retatrutide, a new triple-agonist GLP-1 therapy said to reduce side effects and spare muscle.
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.
An immunologist says Ebola's long incubation period means it could cross borders silently, though risk of spread to the U.S. remains low for now as the African outbreak continues.
American cruise passenger says she is forced to quarantine in Omaha after possible hantavirus exposure aboard the MV Hondius despite testing negative.
A new study suggests the APOE2 longevity gene may protect the brain from Alzheimer's by helping neurons repair DNA damage and resist cell aging.
Prime Minister Albanese announces a $5 million grant for MCRI to launch a pioneering research team focused on preventing childhood health conditions.
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
People who regularly visit museums or engage in creative activities may age more slowly on a biological level, according to a new UK research study.
Fitness trainer Mark Langowski, known as @bodybymark, hosted a NYC pushup and plank competition to get people moving. He shares his best tips for getting stronger.
An ancient Chinese exercise called baduanjin could help lower blood pressure as effectively as some medications, according to a new clinical trial.
© 2026 WFLM-HD3, WSFS-HD3, Vic Canales Media Group LLC
Built on Envisionwise Technology.
